Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Lung Neoplasms × Histocompatibility Testing × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 1 Prostatic Neoplasms 1 Pancreatitis 1 Pancreatic Diseases 1 Melanoma 1 Lung Neoplasms 1 Head and Neck Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Adenoma, Islet Cell 1

Interventions

pembrolizumab 45 Carboplatin 38 Pemetrexed 34 Magnetic Resonance Spectroscopy 33 Specimen Handling 32 Cisplatin 25 Blood Specimen Collection 20 Paclitaxel 15 Radiosurgery 14 durvalumab 13 Radiotherapy 13 Gemcitabine 12 Bevacizumab 12 osimertinib 11 atezolizumab 11 Biopsy 11 Practice Guidelines as Topic 10 Nivolumab 10 Educational Status 9 130-nm albumin-bound paclitaxel 9 X-Rays 8 Standard of Care 8 Immunoglobulin G 8 Docetaxel 8 Surveys and Questionnaires 7 Disulfides 7 Cetuximab 7 Taxes 6 Etoposide 6 Drug Therapy 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05092009 2025-07-15

IPON-3

Maastricht Radiation Oncology

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡